TANG KEVIN purchased $27K of BOLD (indirect holdings)
TANG KEVIN purchased 11,162 indirectly-held shares of Boundless Bio, Inc. (BOLD) at $2.40 across 3 trades over 2026-11-03 to 2026-11-05. Filed jointly with TANG CAPITAL MANAGEMENT LLC (10% owner).
How this was made
The 30-second read
Why it matters
The filing is a primary disclosure but the transaction size is trivial, offering limited trading insight.
Market read
Minimal impact; the insider purchase is too small to affect price materially.
What to watch
Kevin Tang already holds a large stake; additional shares may have little incremental meaning.
Background
Boundless Bio, Inc. (BOLD) filed a Form 4 indicating a $27K insider purchase by a 10% owner.
Ticker impact
Form 4 shows insider Kevin Tang bought 11,162 shares for $26,788.80, increasing his stake to over 3 million shares.
minor upward pressure as market prices in insider buying
The transaction is a primary filing, but the dollar amount is under $30k, unlikely to move the stock materially.
Market effects
None; insider activity does not affect the broader biotech sector.
None; transaction is company‑specific.
None
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a bullish signal.
Key entities
- companyBoundless Bio, Inc.
Biotech firm listed on US exchanges under ticker BOLD.
- insiderKevin Tang
10% owner of Boundless Bio who made the purchase.
